85 related articles for article (PubMed ID: 16260777)
1. Decreased subunit stability as a novel mechanism for potassium current impairment by a KCNQ2 C terminus mutation causing benign familial neonatal convulsions.
Soldovieri MV; Castaldo P; Iodice L; Miceli F; Barrese V; Bellini G; Miraglia del Giudice E; Pascotto A; Bonatti S; Annunziato L; Taglialatela M
J Biol Chem; 2006 Jan; 281(1):418-28. PubMed ID: 16260777
[TBL] [Abstract][Full Text] [Related]
2. M channel KCNQ2 subunits are localized to key sites for control of neuronal network oscillations and synchronization in mouse brain.
Cooper EC; Harrington E; Jan YN; Jan LY
J Neurosci; 2001 Dec; 21(24):9529-40. PubMed ID: 11739564
[TBL] [Abstract][Full Text] [Related]
3. KCNQ2 mutations cause unique neonatal behavior arrests without motor seizures: Functional characterization.
Wong SH; Liou YM; Yang JJ; Lee IC
Epilepsy Behav; 2024 Jul; 156():109798. PubMed ID: 38788659
[TBL] [Abstract][Full Text] [Related]
4. Stoichiometry of expressed KCNQ2/KCNQ3 potassium channels and subunit composition of native ganglionic M channels deduced from block by tetraethylammonium.
Hadley JK; Passmore GM; Tatulian L; Al-Qatari M; Ye F; Wickenden AD; Brown DA
J Neurosci; 2003 Jun; 23(12):5012-9. PubMed ID: 12832524
[TBL] [Abstract][Full Text] [Related]
5. KCNQ channels mediate IKs, a slow K+ current regulating excitability in the rat node of Ranvier.
Schwarz JR; Glassmeier G; Cooper EC; Kao TC; Nodera H; Tabuena D; Kaji R; Bostock H
J Physiol; 2006 May; 573(Pt 1):17-34. PubMed ID: 16527853
[TBL] [Abstract][Full Text] [Related]
6. Functional characterization and in vitro pharmacological rescue of KCNQ2 pore mutations associated with epileptic encephalopathy.
Yang GM; Tian FY; Shen YW; Yang CY; Yuan H; Li P; Gao ZB
Acta Pharmacol Sin; 2023 Aug; 44(8):1589-1599. PubMed ID: 36932231
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic and functional assessment of two novel KCNQ2 gain-of-function variants Y141N and G239S and effects of amitriptyline treatment.
Bayat A; Iavarone S; Miceli F; Jakobsen AV; Johannesen KM; Nikanorova M; Ploski R; Szymanska K; Flamini R; Cooper EC; Weckhuysen S; Taglialatela M; Møller RS
Neurotherapeutics; 2024 Jan; 21(1):e00296. PubMed ID: 38241158
[TBL] [Abstract][Full Text] [Related]
8. Flexible Stoichiometry: Implications for KCNQ2- and KCNQ3-Associated Neurodevelopmental Disorders.
Springer K; Varghese N; Tzingounis AV
Dev Neurosci; 2021; 43(3-4):191-200. PubMed ID: 33794528
[TBL] [Abstract][Full Text] [Related]
9. Molecular correlates of the M-current in cultured rat hippocampal neurons.
Shah M; Mistry M; Marsh SJ; Brown DA; Delmas P
J Physiol; 2002 Oct; 544(Pt 1):29-37. PubMed ID: 12356878
[TBL] [Abstract][Full Text] [Related]
10. Made for "anchorin": Kv7.2/7.3 (KCNQ2/KCNQ3) channels and the modulation of neuronal excitability in vertebrate axons.
Cooper EC
Semin Cell Dev Biol; 2011 Apr; 22(2):185-92. PubMed ID: 20940059
[TBL] [Abstract][Full Text] [Related]
11. Potassium channels act as chemosensors for solute transporters.
Manville RW; Abbott GW
Commun Biol; 2020 Feb; 3(1):90. PubMed ID: 32111967
[TBL] [Abstract][Full Text] [Related]
12. Homomeric and heteromeric assembly of KCNQ (Kv7) K+ channels assayed by total internal reflection fluorescence/fluorescence resonance energy transfer and patch clamp analysis.
Bal M; Zhang J; Zaika O; Hernandez CC; Shapiro MS
J Biol Chem; 2008 Nov; 283(45):30668-76. PubMed ID: 18786918
[TBL] [Abstract][Full Text] [Related]
13. KCNQ2/3 Gain-of-Function Variants and Cell Excitability: Differential Effects in CA1 versus L2/3 Pyramidal Neurons.
Varghese N; Moscoso B; Chavez A; Springer K; Ortiz E; Soh H; Santaniello S; Maheshwari A; Tzingounis AV
J Neurosci; 2023 Sep; 43(38):6479-6494. PubMed ID: 37607817
[TBL] [Abstract][Full Text] [Related]
14. A novel homozygous KCNQ3 loss-of-function variant causes non-syndromic intellectual disability and neonatal-onset pharmacodependent epilepsy.
Lauritano A; Moutton S; Longobardi E; Tran Mau-Them F; Laudati G; Nappi P; Soldovieri MV; Ambrosino P; Cataldi M; Jouan T; Lehalle D; Maurey H; Philippe C; Miceli F; Vitobello A; Taglialatela M
Epilepsia Open; 2019 Sep; 4(3):464-475. PubMed ID: 31440727
[TBL] [Abstract][Full Text] [Related]
15. Two types of K(+) channel subunit, Erg1 and KCNQ2/3, contribute to the M-like current in a mammalian neuronal cell.
Selyanko AA; Hadley JK; Wood IC; Abogadie FC; Delmas P; Buckley NJ; London B; Brown DA
J Neurosci; 1999 Sep; 19(18):7742-56. PubMed ID: 10479678
[TBL] [Abstract][Full Text] [Related]
16. Nervous system KV7 disorders: breakdown of a subthreshold brake.
Maljevic S; Wuttke TV; Lerche H
J Physiol; 2008 Apr; 586(7):1791-801. PubMed ID: 18238816
[TBL] [Abstract][Full Text] [Related]
17. MLe-KCNQ2: An Artificial Intelligence Model for the Prognosis of Missense
Saez-Matia A; Ibarluzea MG; M-Alicante S; Muguruza-Montero A; Nuñez E; Ramis R; Ballesteros OR; Lasa-Goicuria D; Fons C; Gallego M; Casis O; Leonardo A; Bergara A; Villarroel A
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474157
[TBL] [Abstract][Full Text] [Related]
18. Ancient medicinal plant rosemary contains a highly efficacious and isoform-selective KCNQ potassium channel opener.
Manville RW; Hogenkamp D; Abbott GW
Commun Biol; 2023 Jun; 6(1):644. PubMed ID: 37322081
[TBL] [Abstract][Full Text] [Related]
19. Impaired NaV1.2 function and reduced cell surface expression in benign familial neonatal-infantile seizures.
Misra SN; Kahlig KM; George AL
Epilepsia; 2008 Sep; 49(9):1535-45. PubMed ID: 18479388
[TBL] [Abstract][Full Text] [Related]
20. Identifying mutation hotspots reveals pathogenetic mechanisms of KCNQ2 epileptic encephalopathy.
Zhang J; Kim EC; Chen C; Procko E; Pant S; Lam K; Patel J; Choi R; Hong M; Joshi D; Bolton E; Tajkhorshid E; Chung HJ
Sci Rep; 2020 Mar; 10(1):4756. PubMed ID: 32179837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
